Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses
| dc.contributor.author | Siamopoulos, K. C. | en |
| dc.contributor.author | Eleftheriades, E. G. | en |
| dc.contributor.author | Pappas, M. | en |
| dc.contributor.author | Sferopoulos, G. | en |
| dc.contributor.author | Tsolas, O. | en |
| dc.date.accessioned | 2015-11-24T19:00:23Z | |
| dc.date.available | 2015-11-24T19:00:23Z | |
| dc.identifier.issn | 0301-0163 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19525 | |
| dc.rights | Default Licence | - |
| dc.subject | Adrenocorticotropic Hormone/*blood | en |
| dc.subject | Adult | en |
| dc.subject | Corticotropin-Releasing Hormone/*diagnostic use/pharmacokinetics/pharmacology | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Hydrocortisone/*blood | en |
| dc.subject | Hypothalamo-Hypophyseal System/*physiopathology | en |
| dc.subject | Kidney Failure, Chronic/blood/*physiopathology/therapy | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pituitary-Adrenal System/*physiopathology | en |
| dc.subject | Renal Dialysis | en |
| dc.title | Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses | en |
| heal.abstract | The data on the status of the hypothalamic-pituitary-adrenal (HPA) axis in haemodialysis (HD) patients are conflicting. Moreover, a state reminiscent of Cushing's syndrome has been reported in this group of patients. Corticotropin-releasing hormone (CRH), that is produced by the hypothalamus and modulates the secretion of adrenocorticotropic hormone (ACTH), has been shown to be useful as a provocative test of the HPA axis. We investigated the effect of exogenous ovine CRH (oCRH) on plasma levels of ACTH and cortisol in 13 chronic HD patients. The plasma concentrations of immunoreactive CRH following oCRH administration were similar in patients and controls. In all patients, oCRH given intravenously as bolus injection caused a further increase in the already elevated levels of cortisol. The mean basal plasma levels of ACTH were within the normal range. There was, however, a blunted ACTH response to oCRH. We conclude that the HPA axis in chronic HD patients retains the ability to respond to exogenous oCRH. The patterns of the ACTH and cortisol response to this peptide resemble those observed in chronic stress (depression, anorexia nervosa). Besides, the kinetics of disappearance of oCRH indicate that the kidney may not be the major organ that metabolizes oCRH. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/2851525 | - |
| heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000181019 | - |
| heal.journalName | Horm Res | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 1988 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: